Рефрактерная стенокардия: особенности диагностики и подходы к медикаментозной и немедикаментозной терапии
Download
2. Жарова, Е. А. Триметазидин в комбинированной терапии стенокардии напряжения (ТАСТ – Effect of Trimetazidine in patients with stable effort Angina in Combination with existing Therapy) / Е. А. Жарова, В. К. Лепахин, С. Б. Фитилев и др. // Сердце. – 2002. – № 1. – С. 204–206.
3. Крюков, Н. Н. Ишемическая болезнь сердца. Современные аспекты клиники, диагностики, лечения, профилактики, медицинской реабилитации, экспертизы: монография / Н. Н. Крюков, Е. Н. Николаевский, В. П. Поляков. – Самара, 2010. – С. 149–173.
4. Метелица, В. И. Справочник по клинической фармакологии сердечно-сосудистых лекарственных средств / В. И. Метелица. – М.: Медицинское информационное агентство, 2005. – С. 87–188.
5. Оганов, Р. Г. Профилактика сердечно-сосудистых заболеваний: возможности практического здравоохранения / Р. Г. Оганов // Кардиоваск. тер. и проф. – 2002. – № 1. – С. 5–9.
6. Перепеч, Н. Б. Коррекция частоты сердечных сокращений у больных стабильной ИБС: позиция І-адреноблокаторов / Н. Б. Перепеч // Сердце. – 2008. – Т. 42, № 7. – С. 207–211.
7. Чазов, Е. И. Рациональная фармакотерапия сердечно-сосудистых заболеваний: рук. для практикующих врачей / Е. И. Чазов, Ю. Н. Беленков и др. – М.: Литтерра, 2006. – С. 115–125.
8. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. A report of the American College of Cardiology / American Heart Association Task Forse on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina) // JACC. – 1999. – Vol. 33, № 7. – P. 2092–2197.
9. ACSM’s Guidelines for Exercise Testing and Prescription by American College of Sports Medicine. – Baltimore, Ph.: Williams & Wilkings, 2005. – 366 p.
10. Allen, K. B. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina / K. B. Allen, R. D. Dowling, T. L. Fudge et al. // N. Engl. J. Med. – 1999. – Vol. 341. – P. 1029–1036.
11. American Association for Cardiovascular and Pulmonary Rehabilitation. Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. – Champaign, Ill: Human Kinetics Publishers, 1999.
12. Arora, R. R. The Multicenter study of enhanced external counterpulsation (MUST-EECP): Effect of EECP on exercise-induced myocardial ischemia and anginal episodes / R. R. Arora, T. M. Chou, D. Jain et al. // J. Am. Coll. Cardiol. – 1999. – Vol. 33, № 7. – P. 1833–1840.
13. Baigent, C. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins / C. Baigent, A. Keech, P. M. Kearney et al. // Lancet. – 2005. – Vol. 366. – P. 1267–1278.
14. Belardinelli, R. Effects of moderate exercise training on thallium uptake and contractile response to lowdose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy / R. Belardinelli, D. Georgiou, L. Ginzton et al. // Circulation. – 1998. – Vol. 97. – P. 553–561.
15. Brorsson, B. Smдrtor i blцstet: Operation, ballongvidgning, medicinsk behandlibg. Statens begedning fцr utvдrdering av medicinsk metodik / B. Brorsson, H. Persson, P. Landelius, L. Werkц. – Stockholm, Sweden, 1998. – Report № 140.
16. Channer, K. S. Anxiety and depression in patients with chest pain referred for exercise testing / K. S. Channer, M. Papouchado, M. A. James et al. // Lancet. – 1985. – Vol. 2. – P. 820–822.
17. Chester, M. Draft guidelines for the management of refractory angina on behalf of the UK Refractory Angina Group / Chester M. // Eur. Heart J. – 1999. – Vol. 20. – P. 479 (Abstr. Suppl.).
18. Ciopor, M. Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence on angina pectoris in patients with coronary heart disease / M. Ciopor, A. Fischer, J. Turina, O. Hess // Schweiz Rundsch Med. Plax. – 1997. – Vol. 86. – P. 1849–1853.
19. Cohen, M. G. Therapeutic goals in patients with refractory chronic angina / M. G. Cohen, M. P. M. Scirica, E. M. Ohman // Rev. Esp. Cardiol. – 2010. – Vol. 63, № 5. – P. 571–582.
20. Cooley, D. A. Transmyocardial laser revascularization: anatomic evidence of long-term channel patency / D. A. Cooley, O. H. Frazier, K. A. Kadipasaoglu et al. // Tex. Heart Inst. J. – 1994. – Vol. 21. – P. 220–224.
21. Dens, J. A. Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in Leuven / J. A. Dens, W. J. Desmet, P. Coussement et al. // Am. J. Cardiol. – 2001. – Vol. 87, № 1. – P. 28–33.
22. Detre, K. M. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the bypass angioplasty revascularization investigation (BARI) / K. M. Detre, P. Guo, R. Holubkov et al. // Circulation. – 1999. – Vol. 99. – P. 633–640.
23. Detry, J. M. Amlodipine and the total ischemic burden: Circadian Anti-Ischemia Program in Europe (CAPE) trial – Methodology, safety and toleration / J. M. Detry // Cardiology. – 1994. – Vol. 85. – P. 24–30 (Suppl. 2).
24. Di Pede, F. Immediate and long-term clinical outcome after spinal cord stimulation for refractory stable angina pectoris / F. Di Pede, G. A. Lanza, G. Zuin et al. // Am. J. Cardiol. – 2003. – Vol. 91. – P. 951–955.
25. Eastaugh, J. L. Highlighting the need for better patient care in stable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients / J. L. Eastaugh, Calvert M. J., N. Freemantle // Fam. Pract. – 2005. – Vol. 22, № 1. – P. 43–50.
26. Ehsani, A. Cardiac effects of prolonged and intense exercise training in patients with coronary artery disease / A. Ehsani, W. Martin, G. Heath, E. Coyle // Am. J. Cardiol. – 1982. – Vol. 50. – P. 236–254.
27. Epstein, S. Current concepts, myocardial ischemia: silent or symptomatic / S. Epstein, A. Quyyumi, R. Bonow // N. Engl. J. Med. – 1988. – Vol. 318. – P. 1038–1043.
28. FEMINA Study Group of the Working Group of Cardiovascular Research. The Neterlands. Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta-blokade // Eur. Heart J. – 1997. – Vol. 18. – P. 1755–1764.
29. Fox, K. Guidelines on the manamegent of stable angina pectoris: executive summary: the Task Forse on the Management of Stable Angina Pectoris of the European Society of Cardiology / K. Fox, M. A. Garcia, D. Ardissino el al. // Eur. Heart J. – 2006. – Vol. 27, № 11. – P. 1341–1381.
30. Fox, К. The Total Ischemic Burden Trial (TIBET) / К. Fox, D. Mulkahy, I. Findlay // Eur. Heart J. – 1996. – Vol. 17. – P. 96–103.
31. Frazier, O. H. Transmyocardial revascularization with a carbon dioxide laser in patients with endstage coronary artery disease / O. H. Frazier, R. J. March, K. A. Horvath // N. Engl. J. Med. – 1999. – Vol. 341. – P. 1021–1028.
32. Gan, L. Distinct regulation of vascular endothelial growth factor in intact human conduit vessels exposed to laminar fluid shear stress and pressure / L. Gan, M. Miocic, R. Doroudi et al. // Biochem. Biophys. Res. Commun. – 2000. – Vol. 272. – P. 490–496.
33. Gibbons, R. J. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina — summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina) / R. J. Gibbons, J. Abrams, K. Chatterjee et al. // J. Am. Coll. Cardiol. – 2003. – Vol. 41. – P. 159–168.
34. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology // Eur. Heart J. – 2006. – Vol. 27. – P. 1341–1381.
35. Harrington, R. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy / R. Harrington // Chest. – Vol. 126. – 2004. – P. 513–548 (Suppl. 3).
36. Hautvast, R. W. Effect of spinal cord stimulation on heart rate variability and myocardial ischemia in patients with chroni intractable angina pectoris – a prospective ambulatory electrocardiographic study / R. W. Hautvast, J. Brouwer, M. J. DeJongste, K. I. Lie // Clin. Cardiol. – 1998. – Vol. 21. – P. 33–38.
37. Jorgensen, B. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES) / B. Jorgensen, S. Simonsen, K. Endresen // J. Am. Coll. Cardiol. – 2000. – Vol. 35, № 3. – P. 592–599.
38. Kulkarni, S. P. Long-term adherence with cardiovascular drug regimens / S. P. Kulkarni, K. P. Alexander, B. Lytle et al. // Am. Heart J. – 2006. – Vol. 151, № 1. – P. 185–191.
39. Kumar, K. Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome / K. Kumar et al. // Pain. – 2007. – Vol. 132. – P. 179–188.
40. Kwong, K. F. Transmyocardial laser treatment denervates canine myocardium / K. F. Kwong, G. K. Kanellopoulos, J. C. Nickols et al. // J. Thorac. Cardiovasc. Surg. – 1997. – Vol. 114. – P. 883–889.
41. Lаwson, W. E. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study / W. E. Lаwson, J. C. Hui, P. F. Cohn // Clin. Cardiol. – 2000. – Vol. 23, № 4. – P. 254–258.
42. Lаwson, W. E. Two-years outcomes in patients with mild refractory angina treated with enhanced external counterpulsation / W. E. Lawson, J. C. Hui, E. D. Kennard et al. // Clin. Cardiol. – 2006. – Vol. 29, № 2. – P. 69–73.
43. Leon, A. S. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. American Heart Association; Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention); Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); American Association of Cardiovascular and Pulmonary Rehabilitation / A. S. Leon, B. A. Franklin, F. Costa et al. // Circulation. – 2005. – Vol. 111, № 3. – P. 369–376.
44. Mannheimer, C. Electrical stimulation versus coronary artery by-pass surgery in severe angina pectoris: the ESBY study / C. Mannheimer, T. Eliasson, L. E. Augustinsson et al. // Circulation. – 1998. – Vol. 97. – P. 1157–1163.
45. Mannheimer, C. The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina / C. Mannheimer, P. Camici, M. R. Chester, // Eur. Heart. J. – 2002. – Vol. 23. – P. 355–370.
46. Mannheimer, C. Transcutaneous electrical nerve stimulation (TENS) in angina pectoris / C. Mannheimer, C. A. Carlsson, A. Vedin, C. Wilhelmsson et al. // Pain. – 1986. – Vol. 26. – P. 291–300.
47. Marzilli, M. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials / M. Marzilli, W. W. Klein // Coronary Artery Dis. – 2003. – Vol. 14. – P. 171–179.
48. Michaels, A. D. Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation / A. D. Michaels, M. Accad, T. A. Ports, W. Grossman // Circulation. – 2002. – Vol. 106. – P. 1237–1242.
49. Moore, R. K. Health-related quality of life of patients with refractory angina before and one year enrolment onto a refractory angina program / R. K. Moore, D. Groves, S. Bateson et al. // Eur. J. Pain. – 2005. – Vol. 9. – P. 305–310.
50. Niebauer, J. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise / J. Niebauer, R. Hambrecht, T. Velich et al. // Circulation. – 1997. – Vol. 96. – P. 2534–2541.
51. Nissen, S. E. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial / S. E. Nissen, E. M. Tuzcu, P. Libby et al. // JAMA. – 2004. – Vol. 292, № 18. – P. 2217–2225.
52. Nissen, S. E. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial / S. E. Nissen, E. M. Tuzcu, P. Schoenhagen et al. // JAMA. – 2004. – Vol. 291. – P. 1071–1080.
53. Norrsell, H. Effects of pacing-induced myocardial stress and spinal cord stimulation on whole body and cardiac norepinephrine spillover / H. Norrsell, T. Eliasson, C. Mannheimer et al. // Eur. Heart. J. 1997. – Vol. 18. – P. 1890–1896.
54. Piepoli, M. F. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation / M. F. Piepoli, U. Corra, W. Benzer et al. // Eur. J. Cardiovasc. Prev. Rehabil. – 2010. – Vol. 17. – P. 1–17.
55. Rehuquist, N. The Angina Prognosis Study In Stockholm (APSIS) / N. Rehuquist, P. Hjeurdahl, E. Billings et al. // Eur. Heart J. – 1996. – Vol. 17. – P. 76–81.
56. Sacks, F. M. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators / F. M. Sacks, M. A. Pfeffer, L. A. Moye et al. // N. Engl. J. Med. – 1996. – Vol. 335. – P. 1001–1009.
57. Sanderson, J. E. The effect of transcutaneous electrical nerve stimulation (TENS) on autonomic cardiovascular reflexes / J. E. Sanderson, B. Tomlinson, M. S. Lau et al. // Clin. Auton. Res. – 1995. – Vol. 5. – P. 81–84.
58. Schang, S. Transient asymptomatic ST segment depression during daily activity / S. Schang, C. Pepine // Am. J. Cardiol. – 1977. – Vol. 39. – P. 396–402.
59. Shechter, M. External counterpulsation therapy improves endothelial function in patients with angina pectoris / M. Shechter, S. Matetzky, M. S. Feinberg et al. // JACC. – 2003. – Vol. 42, № 12. – P. 2090–2095.
60. Sigel, J. E. Transmyocardial laser revascularization: three sequential autopsy cases / J. E. Sigel, C. M. Abramovich, B. W. Lytle, N. B. Ratliff // J. Thorac. Cardiovasc. Surg. – 1998. – Vol. 115. – P. 1381–1385.
61. Soran, О. Enhanced external couterpulsation as treatment for chronic angina in patients with left ventricular disfunction: a report from the International EECP Patients Registry (IERP) / О. Soran, E. D. Kennard, S. F. Kelsey et al. // Congest. Heart Fail. – 2002. – Vol. 8. – P. 297–302.
62. Soran, О. Impact of external counterpulsation treatment on emergency department visits and hospitalization in refractory angina patients with left ventricular dysfunction / О. Soran, E. D. Kennard, B. A. Bart et al. // Congest. Heart Fail. – 2007. – Vol. 13, № 1. – P. 36–40.
63. Taylor, R. S. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized trials / R. S. Taylor, A. Brown, S. Ebrahim et al. // Am. J. Med. – 2004. – Vol. 116. – P. 682–697.
64. Thadani, U. Medical therapy of stable angina pectoris / U. Thadani // Cardiol. Clin. – 1991. – Vol. 9. – P. 73–87.
65. Urano, H. Enhanced external conterpulsation improves exercise tolerance, educed exercise – induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease / H. Urano, H. Ikeda, T. Hirai et al. // J. Am. Coll. Cardiol.–2001.–Vol. 37, № 1.– P. 93–99.
66. Von Armin, T. Prognostic significance of transient ischemic episodes: response to treatment shows improved prognosis. Results of the Total Ischemic Burden Bisoprolol Study (TIBBS) follow-up / T. Von Armin // J. Am. Coll. Cardiol. – 1996. – Vol. 28, № 1. – P. 20–24.
67. Yang, E. H. Current and future treatment strategies for refractory angina / E. H. Yang, G. W. Barsness, B. J. Gersh et al. // Mayo Clinic. Proc. – 2004. – Vol. 79, № 10. – P. 1284–1292.
References
1. Диагностика и лечение стабильной стенокардии. Российские рекомендации (2-й пересмотр) // Кардиоваск. тер. и проф. – 2008. – Т. 6, № 7 (Прил. 4). – С. 1–40.2. Жарова, Е. А. Триметазидин в комбинированной терапии стенокардии напряжения (ТАСТ – Effect of Trimetazidine in patients with stable effort Angina in Combination with existing Therapy) / Е. А. Жарова, В. К. Лепахин, С. Б. Фитилев и др. // Сердце. – 2002. – № 1. – С. 204–206.
3. Крюков, Н. Н. Ишемическая болезнь сердца. Современные аспекты клиники, диагностики, лечения, профилактики, медицинской реабилитации, экспертизы: монография / Н. Н. Крюков, Е. Н. Николаевский, В. П. Поляков. – Самара, 2010. – С. 149–173.
4. Метелица, В. И. Справочник по клинической фармакологии сердечно-сосудистых лекарственных средств / В. И. Метелица. – М.: Медицинское информационное агентство, 2005. – С. 87–188.
5. Оганов, Р. Г. Профилактика сердечно-сосудистых заболеваний: возможности практического здравоохранения / Р. Г. Оганов // Кардиоваск. тер. и проф. – 2002. – № 1. – С. 5–9.
6. Перепеч, Н. Б. Коррекция частоты сердечных сокращений у больных стабильной ИБС: позиция І-адреноблокаторов / Н. Б. Перепеч // Сердце. – 2008. – Т. 42, № 7. – С. 207–211.
7. Чазов, Е. И. Рациональная фармакотерапия сердечно-сосудистых заболеваний: рук. для практикующих врачей / Е. И. Чазов, Ю. Н. Беленков и др. – М.: Литтерра, 2006. – С. 115–125.
8. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. A report of the American College of Cardiology / American Heart Association Task Forse on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina) // JACC. – 1999. – Vol. 33, № 7. – P. 2092–2197.
9. ACSM’s Guidelines for Exercise Testing and Prescription by American College of Sports Medicine. – Baltimore, Ph.: Williams & Wilkings, 2005. – 366 p.
10. Allen, K. B. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina / K. B. Allen, R. D. Dowling, T. L. Fudge et al. // N. Engl. J. Med. – 1999. – Vol. 341. – P. 1029–1036.
11. American Association for Cardiovascular and Pulmonary Rehabilitation. Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. – Champaign, Ill: Human Kinetics Publishers, 1999.
12. Arora, R. R. The Multicenter study of enhanced external counterpulsation (MUST-EECP): Effect of EECP on exercise-induced myocardial ischemia and anginal episodes / R. R. Arora, T. M. Chou, D. Jain et al. // J. Am. Coll. Cardiol. – 1999. – Vol. 33, № 7. – P. 1833–1840.
13. Baigent, C. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins / C. Baigent, A. Keech, P. M. Kearney et al. // Lancet. – 2005. – Vol. 366. – P. 1267–1278.
14. Belardinelli, R. Effects of moderate exercise training on thallium uptake and contractile response to lowdose dobutamine of dysfunctional myocardium in patients with ischemic cardiomyopathy / R. Belardinelli, D. Georgiou, L. Ginzton et al. // Circulation. – 1998. – Vol. 97. – P. 553–561.
15. Brorsson, B. Smдrtor i blцstet: Operation, ballongvidgning, medicinsk behandlibg. Statens begedning fцr utvдrdering av medicinsk metodik / B. Brorsson, H. Persson, P. Landelius, L. Werkц. – Stockholm, Sweden, 1998. – Report № 140.
16. Channer, K. S. Anxiety and depression in patients with chest pain referred for exercise testing / K. S. Channer, M. Papouchado, M. A. James et al. // Lancet. – 1985. – Vol. 2. – P. 820–822.
17. Chester, M. Draft guidelines for the management of refractory angina on behalf of the UK Refractory Angina Group / Chester M. // Eur. Heart J. – 1999. – Vol. 20. – P. 479 (Abstr. Suppl.).
18. Ciopor, M. Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence on angina pectoris in patients with coronary heart disease / M. Ciopor, A. Fischer, J. Turina, O. Hess // Schweiz Rundsch Med. Plax. – 1997. – Vol. 86. – P. 1849–1853.
19. Cohen, M. G. Therapeutic goals in patients with refractory chronic angina / M. G. Cohen, M. P. M. Scirica, E. M. Ohman // Rev. Esp. Cardiol. – 2010. – Vol. 63, № 5. – P. 571–582.
20. Cooley, D. A. Transmyocardial laser revascularization: anatomic evidence of long-term channel patency / D. A. Cooley, O. H. Frazier, K. A. Kadipasaoglu et al. // Tex. Heart Inst. J. – 1994. – Vol. 21. – P. 220–224.
21. Dens, J. A. Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in Leuven / J. A. Dens, W. J. Desmet, P. Coussement et al. // Am. J. Cardiol. – 2001. – Vol. 87, № 1. – P. 28–33.
22. Detre, K. M. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the bypass angioplasty revascularization investigation (BARI) / K. M. Detre, P. Guo, R. Holubkov et al. // Circulation. – 1999. – Vol. 99. – P. 633–640.
23. Detry, J. M. Amlodipine and the total ischemic burden: Circadian Anti-Ischemia Program in Europe (CAPE) trial – Methodology, safety and toleration / J. M. Detry // Cardiology. – 1994. – Vol. 85. – P. 24–30 (Suppl. 2).
24. Di Pede, F. Immediate and long-term clinical outcome after spinal cord stimulation for refractory stable angina pectoris / F. Di Pede, G. A. Lanza, G. Zuin et al. // Am. J. Cardiol. – 2003. – Vol. 91. – P. 951–955.
25. Eastaugh, J. L. Highlighting the need for better patient care in stable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients / J. L. Eastaugh, Calvert M. J., N. Freemantle // Fam. Pract. – 2005. – Vol. 22, № 1. – P. 43–50.
26. Ehsani, A. Cardiac effects of prolonged and intense exercise training in patients with coronary artery disease / A. Ehsani, W. Martin, G. Heath, E. Coyle // Am. J. Cardiol. – 1982. – Vol. 50. – P. 236–254.
27. Epstein, S. Current concepts, myocardial ischemia: silent or symptomatic / S. Epstein, A. Quyyumi, R. Bonow // N. Engl. J. Med. – 1988. – Vol. 318. – P. 1038–1043.
28. FEMINA Study Group of the Working Group of Cardiovascular Research. The Neterlands. Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta-blokade // Eur. Heart J. – 1997. – Vol. 18. – P. 1755–1764.
29. Fox, K. Guidelines on the manamegent of stable angina pectoris: executive summary: the Task Forse on the Management of Stable Angina Pectoris of the European Society of Cardiology / K. Fox, M. A. Garcia, D. Ardissino el al. // Eur. Heart J. – 2006. – Vol. 27, № 11. – P. 1341–1381.
30. Fox, К. The Total Ischemic Burden Trial (TIBET) / К. Fox, D. Mulkahy, I. Findlay // Eur. Heart J. – 1996. – Vol. 17. – P. 96–103.
31. Frazier, O. H. Transmyocardial revascularization with a carbon dioxide laser in patients with endstage coronary artery disease / O. H. Frazier, R. J. March, K. A. Horvath // N. Engl. J. Med. – 1999. – Vol. 341. – P. 1021–1028.
32. Gan, L. Distinct regulation of vascular endothelial growth factor in intact human conduit vessels exposed to laminar fluid shear stress and pressure / L. Gan, M. Miocic, R. Doroudi et al. // Biochem. Biophys. Res. Commun. – 2000. – Vol. 272. – P. 490–496.
33. Gibbons, R. J. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina — summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina) / R. J. Gibbons, J. Abrams, K. Chatterjee et al. // J. Am. Coll. Cardiol. – 2003. – Vol. 41. – P. 159–168.
34. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology // Eur. Heart J. – 2006. – Vol. 27. – P. 1341–1381.
35. Harrington, R. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy / R. Harrington // Chest. – Vol. 126. – 2004. – P. 513–548 (Suppl. 3).
36. Hautvast, R. W. Effect of spinal cord stimulation on heart rate variability and myocardial ischemia in patients with chroni intractable angina pectoris – a prospective ambulatory electrocardiographic study / R. W. Hautvast, J. Brouwer, M. J. DeJongste, K. I. Lie // Clin. Cardiol. – 1998. – Vol. 21. – P. 33–38.
37. Jorgensen, B. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES) / B. Jorgensen, S. Simonsen, K. Endresen // J. Am. Coll. Cardiol. – 2000. – Vol. 35, № 3. – P. 592–599.
38. Kulkarni, S. P. Long-term adherence with cardiovascular drug regimens / S. P. Kulkarni, K. P. Alexander, B. Lytle et al. // Am. Heart J. – 2006. – Vol. 151, № 1. – P. 185–191.
39. Kumar, K. Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome / K. Kumar et al. // Pain. – 2007. – Vol. 132. – P. 179–188.
40. Kwong, K. F. Transmyocardial laser treatment denervates canine myocardium / K. F. Kwong, G. K. Kanellopoulos, J. C. Nickols et al. // J. Thorac. Cardiovasc. Surg. – 1997. – Vol. 114. – P. 883–889.
41. Lаwson, W. E. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study / W. E. Lаwson, J. C. Hui, P. F. Cohn // Clin. Cardiol. – 2000. – Vol. 23, № 4. – P. 254–258.
42. Lаwson, W. E. Two-years outcomes in patients with mild refractory angina treated with enhanced external counterpulsation / W. E. Lawson, J. C. Hui, E. D. Kennard et al. // Clin. Cardiol. – 2006. – Vol. 29, № 2. – P. 69–73.
43. Leon, A. S. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. American Heart Association; Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention); Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); American Association of Cardiovascular and Pulmonary Rehabilitation / A. S. Leon, B. A. Franklin, F. Costa et al. // Circulation. – 2005. – Vol. 111, № 3. – P. 369–376.
44. Mannheimer, C. Electrical stimulation versus coronary artery by-pass surgery in severe angina pectoris: the ESBY study / C. Mannheimer, T. Eliasson, L. E. Augustinsson et al. // Circulation. – 1998. – Vol. 97. – P. 1157–1163.
45. Mannheimer, C. The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina / C. Mannheimer, P. Camici, M. R. Chester, // Eur. Heart. J. – 2002. – Vol. 23. – P. 355–370.
46. Mannheimer, C. Transcutaneous electrical nerve stimulation (TENS) in angina pectoris / C. Mannheimer, C. A. Carlsson, A. Vedin, C. Wilhelmsson et al. // Pain. – 1986. – Vol. 26. – P. 291–300.
47. Marzilli, M. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials / M. Marzilli, W. W. Klein // Coronary Artery Dis. – 2003. – Vol. 14. – P. 171–179.
48. Michaels, A. D. Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation / A. D. Michaels, M. Accad, T. A. Ports, W. Grossman // Circulation. – 2002. – Vol. 106. – P. 1237–1242.
49. Moore, R. K. Health-related quality of life of patients with refractory angina before and one year enrolment onto a refractory angina program / R. K. Moore, D. Groves, S. Bateson et al. // Eur. J. Pain. – 2005. – Vol. 9. – P. 305–310.
50. Niebauer, J. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise / J. Niebauer, R. Hambrecht, T. Velich et al. // Circulation. – 1997. – Vol. 96. – P. 2534–2541.
51. Nissen, S. E. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial / S. E. Nissen, E. M. Tuzcu, P. Libby et al. // JAMA. – 2004. – Vol. 292, № 18. – P. 2217–2225.
52. Nissen, S. E. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial / S. E. Nissen, E. M. Tuzcu, P. Schoenhagen et al. // JAMA. – 2004. – Vol. 291. – P. 1071–1080.
53. Norrsell, H. Effects of pacing-induced myocardial stress and spinal cord stimulation on whole body and cardiac norepinephrine spillover / H. Norrsell, T. Eliasson, C. Mannheimer et al. // Eur. Heart. J. 1997. – Vol. 18. – P. 1890–1896.
54. Piepoli, M. F. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation / M. F. Piepoli, U. Corra, W. Benzer et al. // Eur. J. Cardiovasc. Prev. Rehabil. – 2010. – Vol. 17. – P. 1–17.
55. Rehuquist, N. The Angina Prognosis Study In Stockholm (APSIS) / N. Rehuquist, P. Hjeurdahl, E. Billings et al. // Eur. Heart J. – 1996. – Vol. 17. – P. 76–81.
56. Sacks, F. M. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators / F. M. Sacks, M. A. Pfeffer, L. A. Moye et al. // N. Engl. J. Med. – 1996. – Vol. 335. – P. 1001–1009.
57. Sanderson, J. E. The effect of transcutaneous electrical nerve stimulation (TENS) on autonomic cardiovascular reflexes / J. E. Sanderson, B. Tomlinson, M. S. Lau et al. // Clin. Auton. Res. – 1995. – Vol. 5. – P. 81–84.
58. Schang, S. Transient asymptomatic ST segment depression during daily activity / S. Schang, C. Pepine // Am. J. Cardiol. – 1977. – Vol. 39. – P. 396–402.
59. Shechter, M. External counterpulsation therapy improves endothelial function in patients with angina pectoris / M. Shechter, S. Matetzky, M. S. Feinberg et al. // JACC. – 2003. – Vol. 42, № 12. – P. 2090–2095.
60. Sigel, J. E. Transmyocardial laser revascularization: three sequential autopsy cases / J. E. Sigel, C. M. Abramovich, B. W. Lytle, N. B. Ratliff // J. Thorac. Cardiovasc. Surg. – 1998. – Vol. 115. – P. 1381–1385.
61. Soran, О. Enhanced external couterpulsation as treatment for chronic angina in patients with left ventricular disfunction: a report from the International EECP Patients Registry (IERP) / О. Soran, E. D. Kennard, S. F. Kelsey et al. // Congest. Heart Fail. – 2002. – Vol. 8. – P. 297–302.
62. Soran, О. Impact of external counterpulsation treatment on emergency department visits and hospitalization in refractory angina patients with left ventricular dysfunction / О. Soran, E. D. Kennard, B. A. Bart et al. // Congest. Heart Fail. – 2007. – Vol. 13, № 1. – P. 36–40.
63. Taylor, R. S. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized trials / R. S. Taylor, A. Brown, S. Ebrahim et al. // Am. J. Med. – 2004. – Vol. 116. – P. 682–697.
64. Thadani, U. Medical therapy of stable angina pectoris / U. Thadani // Cardiol. Clin. – 1991. – Vol. 9. – P. 73–87.
65. Urano, H. Enhanced external conterpulsation improves exercise tolerance, educed exercise – induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease / H. Urano, H. Ikeda, T. Hirai et al. // J. Am. Coll. Cardiol.–2001.–Vol. 37, № 1.– P. 93–99.
66. Von Armin, T. Prognostic significance of transient ischemic episodes: response to treatment shows improved prognosis. Results of the Total Ischemic Burden Bisoprolol Study (TIBBS) follow-up / T. Von Armin // J. Am. Coll. Cardiol. – 1996. – Vol. 28, № 1. – P. 20–24.
67. Yang, E. H. Current and future treatment strategies for refractory angina / E. H. Yang, G. W. Barsness, B. J. Gersh et al. // Mayo Clinic. Proc. – 2004. – Vol. 79, № 10. – P. 1284–1292.
